Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared Matthew Kurian’s, Assistant Professor of Medicine at the University of Kentucky College of Medicine and Physician at St. Elizabeth Healthcare, post on LinkedIn, adding:
“Congratulations to my friend and partner, Matthew Kurian representing St. Elizabeth Healthcare and St. Elizabeth Physicians so well. Fantastic insights at the most important podium in Oncology.
Well done, Matt, Jasmin Hundal on both of your presentations. What an honor for you both this early in your careers!
Highly recommend following their posts – high quality insights from these two future big leaders in Oncology.”
Quoting Matthew Kurian’s post:
“ASCO 2026 Day 2: Innovation
Started the day by giving my very first podium presentation on the ASCO stage, discussing the intersection of AI, patients, trainees, and the global oncology workforce with a powerhouse of amazing oncologists Debra Patt, Eleonora Teplinsky and Aakash Desai! Fantastic panel and great discussion!
Recorded an awesome Breast Cancers Today interview about changing landscape HR+ updates in the adjuvant space with my good friend and colleague Sara Nunnery – so proud of the OncLive podcast she’s built and the impact she’s making for our oncology community.
Ended the meeting filming a fantastic roundtable discussion on the everchanging landscape of HER2+ breast cancer with leaders I greatly admire: Paolo Tarantino, Margaret Gatti-Mays, and Maryam Lustberg.
And along the way, we witnessed what may become one of the most important stories of this meeting – a breakthrough in pancreatic cancer history! Ending the day flying back and catching up with my mentor and colleague Daniel Flora!
ASCO is always about the data. But it’s also about the people, the ideas, and the collaborations that push our field forward!
Until next year, Chicago!”
Other articles featuring Douglas Flora and Matthew Kurian on OncoDaily.
